AxoGen Announces Closing of Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/7/2026
- S&P closes at record high as soft jobs report eases rate-hike concerns
- US suffers unexpected job losses in July, markets dial back rate hike expectations
- Brent climbs $1 on uncertainty over end to Iran war
- Atlassian results seen as 'game changer' for AI kills software worries
- The Trade Desk hit by Wall St downgrades after disappointing Q2 results, outlook
- Trump held multiple undisclosed calls with Fed Chair Warsh, reports say
- Citi says buy the pullback in memory stocks as upcycle is still in early innings
- Stocks close lower as investors eye Mideast talks, earnings
- The Trade Desk Inc. (TTD) Tops Q2 EPS by 16c, Misses on Revenue; Offers Weak Q3 Revenue Guidance
- Apollo to acquire easyJet for £5.7B in cash deal
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
- After-Hours Stock Movers: PLTR, SNAP, ON, ICHR, WGS, WHR
- After-Hours Stock Movers: AAPL, AMZN, COIN, RBLX, RDDT, AXTI, FND, WU, GDDY
AxoGen, Inc. (AXGN) PT Raised to $27 at Wedbush Following Investor Day
November 21, 2017 9:44 AM ESTWedbush raised its price target on AxoGen, Inc. (NASDAQ: AXGN) to $27.00 (from $22.00) while maintaining a Outperform rating following the company's investor day. Analyst Tao Levy came away with greater confidence and clarity around the company's new market opportunities within peripheral nerve repair.
Management... More
AxoGen, Inc. (AXGN) PT Raised to $27 at JMP Securities Following Analyst Day
November 21, 2017 8:04 AM ESTJMP Securities raised its price target on AxoGen, Inc. (NASDAQ: AXGN) to $27.00 (from $25.00) while maintaining a Market Outperform rating following the company's analyst day. JMP's new $27 target is based on 8-9x EV/Sales on 2019 revenue estimates of $105 mln.
The company continued... More
